A Truncated progesterone receptor (PR-M) localizes to the mitochondrion and controls cellular respiration

Molecular Endocrinology

Volumn 27, Issue 5, 2013, Pages 741-753

  Dai, Qunsheng ^a   Shah, Anish A ^a   Garde, Rachana V ^a   Yonish, Bryan A ^a   Zhang, Li ^b   Medvitz, Neil A ^a   Miller, Sara E ^a   Hansen, Elizabeth L ^a   Dunn, Carrie N ^a   Price, Thomas M ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Shenzhen Maternal and Children's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; HYBRID PROTEIN; MITOCHONDRIAL PROTEIN; PROGESTERONE RECEPTOR; PROHIBITIN; SYNTAXIN; UBIQUINOL CYTOCHROME C REDUCTASE; VOLTAGE DEPENDENT ANION CHANNEL 1;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BASAL METABOLIC RATE; CELL ENERGY; CELL RESPIRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; ENDOPLASMIC RETICULUM; ENERGY YIELD; GENE SILENCING; GENETIC TRANSCRIPTION; HEART MITOCHONDRION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL TARGETING SIGNAL; MITOCHONDRION; NUCLEAR LOCALIZATION SIGNAL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTON TRANSPORT;

BASE PAIRING; BLOTTING, NORTHERN; CELL LINE, TUMOR; CELL RESPIRATION; FEMALE; HUMANS; MASS SPECTROMETRY; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; MITOCHONDRIAL PROTEINS; OXYGEN; PEPTIDES; PROGESTINS; PROTEIN TRANSPORT; RECEPTORS, PROGESTERONE; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84876868498     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1292     Document Type: Article

References (60)

1. Wen DX, Xu YF, Mais DE, Goldman ME, McDonell DP. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol. 1994; 14:8356-8364.
2. Jacobsen BM, Richer JK, Sartorius CA, Horwitz KB. Expression profiling of human breast cancers and gene regulation by progesterone receptors. J Mammary Gland Biol Neoplasia. 2003;8:257-268.
3. Tian J, Kim S, Heilig E, Ruderman J. Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation. Proc Natl Acad Sci U S A. 2000;97:14358-14363.
4. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci U S A. 2003;100:2231-2236.
5. Meyer C, Schmid R, Scriba PC, Wehling M. Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem. 1996;239:726-731.
6. Gerdes D, Wehling M, Leube B, Falkenstein E. Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem. 1998;379:907-911.
7. Boonyaratanakornkit V, Scott MP, Ribon V, et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell. 2001;8:269-280.
8. Boonyaratanakornkit V, McGowan E, Sherman L, Mancini MA, Cheskis BJ, Edwards DP. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. Mol Endocrinol. 2007;21:359-375.
9. Saner KJ, Welter BH, Zhang F, et al. Cloning and expression of a novel, truncated progesterone receptor. Mol Cell Endocrinol. 2003; 200:155-163.
10. Sartorius CA, Groshong SD, Miller LA, et al. New T47D breast cancer cell lines for the independent study of progesterone B-and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res. 1994;54:3868-3877.
11. Price TM, Hansen EL, Oliver TN. Immunofluorescent localization of a novel progesterone receptor(s) in a T47D-Y breast cancer cell line lacking genomic progesterone receptor expression. J Soc Gynecol Investig. 2005;12:610-616.
12. Wilm M, Shevchenko A, Houthaeve T, et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature. 1996;379:466-469.
13. Scholte HR, Yu Y, Ross JD, Oosterkamp II, Boonman AM, Busch HF. Rapid isolation of muscle and heart mitochondria, the lability of oxidation phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds. Mol Cell Biochem. 1997;174:61-66.
14. Everberg H, Sivars U, Emanuelsson C, et al. Protein pre-fractionation in detergent-polymer aqueous two-phase systems for facilitated proteomic studies of membrane proteins. J Chromatogr A. 2004;1029:113-124.
15. Greenawalt J. The isolation of outer and inner mitochondrial membranes. Methods Enzymol. 1974;31:310-323.
16. Behera MA, Dai Q, Garde R, Saner C, Jungheim E, Price TM. Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells. Am J Physiol Endocrinol Metab. 2009;297:E1089-E1096.
17. Huang S. Development of a high throughput screening assay for mitochondrial membrane potential in living cells. J Biomol Screen. 2002;7:383-389.
18. T method. Methods. 2001;25:402-408.
19. Guiochon-Mantel A, Loosfelt H, Lescop P, et al. Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell. 1989;57:1147-1154.
20. Wei LL, Krett NL, Francis MD, et al. Multiple progesterone receptor ribonucleic acids and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol Endocrinol. 1988;2:62-72.
21. Wei L, Miner R. Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D. Cancer Res. 1994;54:340-343.
22. Moran TJ, Gray S, Mikosz CA, Conzen SD. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res. 2000;60:867-872.
23. Coppock HA, Gilham DE, Howell A, Clarke RB. Cyclin-dependent kinase inhibitors and basement membrane interact to regulate breast epithelial cell differentiation and acinar morphogenesis. Cell Prolif. 2007;40:721-740.
24. Nardulli AM, Katzenellenbogen BS. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology. 1988;122:1532-1540.
25. Cho H, Aronica SM, Katzenellenbogen BS. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3α,5α-monophosphate, estradiol, insulin-like growth factor-I, and serum factors. Endocrinology. 1994;134:658-664.
26. Samalecos A, Gellersen B. Systematic expression analysis and antibody screening do not support the existence of naturally occurring progesterone receptor (PR)-C, PR-M, or other truncated PR isoforms. Endocrinology. 2008;149:5872-5887.
27. Wan Y, Coxe KK, Thackray VG, Housley PR, Nordeen SK. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor. Mol Endocrinol. 2001;15:17-31.
28. Hanson BJ, Schulenberg B, Patton WF, Capaldi RA. A novel subfractionation approach for mitochondrial proteins: a three-dimensional mitochondrial proteome map. Electrophoresis. 2001;22: 950-959.
29. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem. 2002; 277:5209-5218.
30. Burnstock G. Purine and pyrimidine receptors. Cell Mol Life Sci. 2007;64:1471-1483.
31. MacNamara P, Loughrey HC. Progesterone receptor A and B isoform expression in human osteoblasts. Calcif Tissue Int. 1998;63: 39-46.
32. Bannai H, Tamada Y, Maruyama O, Nakai K, Miyano S. Extensive feature detection of N-terminal protein sorting signals. Bioinformatics. 2002;18:298-305.
33. Rapaport D. Finding the right organelle. Targeting signals in mitochondrial outer-membrane proteins. EMBO Rep. 2003;4:948-952.
34. Taylor SW, Fahy E, Zhang B, et al. Characterization of the human heart mitochondrial proteome. Nat Biotechnol. 2003;21:281-286.
35. Psarra AM, Solakidi S, Trougakos IP, Margaritis LH, Spyrou G, Sekeris CE. Glucocorticoid receptor isoforms in human hepatocarcinoma HepG2 and SaOS-2 osteosarcoma cells: presence of glucocorticoid receptor α in mitochondria and of glucocorticoid receptor β in nucleoli. Int J Biochem Cell Biol. 2005;37:2544-2558.
36. Chen JQ, Delannoy M, Cooke C, Yager JD. Mitochondrial localization of ERα and ERβ in human MCF7 cells. Am J Physiol Endocrinol Metab. 2004;286:E1011-E1022.
37. Yang S, Liu R, Perez E, et al. Mitochondrial localization of estrogen receptor β. Proc Natl Acad Sci U S A. 2004;101:4130-4135.
38. Scheller K, Seibel P, Sekeris C. Glucocorticoid and thyroid hormone receptors in mitochondria of animal cells. Int Rev Cytol. 2003;222: 1-61.
39. -cells. Biochem Biophys Res Commun. 1997;235:349-354.
40. Psarra AM, Solakidi S, Sekeris CE. The mitochondrion as a primary site of action of steroid and thyroid hormones: presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells. Mol Cell Endocrinol. 2006;246:21-33.
41. Tetel MJ, Jung S, Carbajo P, Ladtkow T, Skafar DF, Edwards DP. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. Mol Endocrinol. 1997;11:1114-1128.
42. Cossarizza A, Ceccarelli D, Masini A. Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level. Exp Cell Res. 1996;222:84-94.
43. Mathur A, Hong Y, Kemp BK, Barrientos AA, Erusalimsky JD. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovascular Research. 2000;46:126-138.
44. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem. 1999;264:687-701.
45. Duchen MR, Surin A, Jacobson J. Imaging mitochondrial function in intact cells. Methods Enzymol. 2003;361:353-389.
46. Smiley ST, Reers M, Mottola-Hartshorn C, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A. 1991;88:3671-3675.
47. Di Lisa F, Blank PS, Colonna R, et al. Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J Physiol. 1995;486:1-13.
48. Falk MM, Buehler LK, Kumar NM, Gilula NB. Cell-free synthesis and assembly of connexins into functional gap junction membrane channels. EMBO J. 1997;16:2703-2716.
49. Nicholls DG, Ward MW. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 2000;23:166-174.
50. Robb-Gaspers LD, Burnett P, Rutter GA, Denton RM, Rizzuto R, Thomas AP. Integrating cytosolic calcium signals into mitochondrial metabolic responses. EMBO J. 1998;17:4987-5000.
51. Duchen M. Mitochondria and calcium: from cell signalling to cell death. J Physiol. 2000;529(Pt 1):1:57-68.
52. Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol. 2000;529(Pt 1):1:37-47.
53. Giannoukos G, Szapary D, Smith CL, Meeker JE, Simons SS Jr. New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor-and coregulator-induced changes in progesterone receptor induction properties. Mol Endocrinol. 2001;15:255-270.
54. Sathya G, Jansen MS, Nagel SC, Cook CE, McDonnell DP. Identification and characterization of novel estrogen receptor-β-sparing antiprogestins. Endocrinology. 2002;143:3071-3082.
55. Hulbert AJ, Else PL. Mechanisms underlying the cost of living in animals. Annu Rev Physiol. 2000;62:207-235.
56. Buffenstein R, Poppitt SD, McDevitt RM, Prentice AM. Food intake and the menstrual cycle: a retrospective analysis, with implications for appetite research. Physiol Behav. 1995;58:1067-1077.
57. Webb P. 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr. 1986;44:614-619.
58. Lebenstedt M, Platte P, Pirke KM. Reduced resting metabolic rate in athletes with menstrual disorders. Med Sci Sports Exerc. 1999; 31:1250-1256.
59. Koop-Hoolihan LE, van Loan MD, Wong WW, King JC. Longitudinal assessment of energy balance in well-nourished, pregnant women. Am J Clin Nutr. 1999;69:697-704.
60. Hennessy TG, MacDonald D, Hennessy MS, et al. Serial changes in cardiac output during normal pregnancy: a Doppler ultrasound study. Eur J Obstet Gynecol Reprod Biol. 1996;70:117-122.